Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 20, 2011

Conditions

Human Papillomavirus (HPV)

Interventions

BIOLOGICAL

VGX-3100

DNA plasmid delivered via IM injection + electroporation using CELLECTRA device

Trial Locations (3)

Laurel Highlands, OB/GYN, P.C., Hopwood

Lyndhurst Gynecologic Associates, Winston-Salem

Clinical Research Puerto Rico, San Juan